Retatrutide is a triple agonist, acting at three receptors: GIP, GLP-1, and glucagon. That makes it a focal point for research into how multiple metabolic pathways interact when engaged simultaneously.
Research context
In research models, retatrutide is studied for combined incretin and glucagon-receptor signaling and its effects on energy-balance pathways. It is the most receptor-diverse member of the incretin agonist class we carry.
How it's supplied
Retatrutide ships as a lyophilized powder at ≥98% HPLC purity with a batch-specific COA. Product page: Retatrutide research vials.
Research Use Only. V8 Peptides products are supplied strictly for laboratory research and development and are not intended for human or veterinary use, consumption, or any therapeutic or diagnostic purpose.